ArticleFrontiers in psychiatry2025
Challenges in the development of treatment guidelines for bipolar disorder.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cortisol-Responsive regulation of RASGRP1 in lymphoblastoid cells from individuals with bipolar disorder.BMC research notes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bipolar disorder (BD) is such a complex mental disorder, that even the development of true, reliable, and valid treatment guidelines seems to be a goal almost impossible to achieve. The challenges include the complexity and uniqueness of the clinical picture and the therapeutical options available, special issues including gender, pregnancy, and the different views of therapists and patients. An additional issue is the method for the development of the guidelines, with systematic reviews of the hard evidence to constitute the most recent trend. The grading of the literature findings could be crucial for the whole process, as it is often 'contaminated' by expert opinion. Unfortunately, in the literature, BD is treated as a fragmented condition and each fragment is studied separately as if it were independent. This, in combination with incomplete reporting of the findings, makes the synthesis of the landscape almost impossible and the development of a comprehensive single algorithm for the continuous treatment of BD, extremely difficult. Overall, developing treatment guidelines for BD constitutes a great challenge. This task demands an exhaustive review of the existing literature, searching for unpublished data and digging deep into them to comprehend their nature. It also needs to manage to synthesize the fragmented research picture that refers to isolated faces of the disorder, into a comprehensive network of decision-making that will incorporate the knowledge of the past with decisions for the present by having the mind in the future (the three-fingers rule).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.